Iona Hamilton Selected Research

isosorbide-5-mononitrate (Ismo)

1/2022	Effects of Cilostazol and Isosorbide Mononitrate on Cerebral Hemodynamics in the LACI-1 Randomized Controlled Trial.
5/2019	Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial.
1/2018	Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iona Hamilton Research Topics

Disease

2	Ischemic Stroke 01/2022 - 05/2019
2	Lacunar Stroke 05/2019 - 01/2018
1	Disease Progression 03/2021
1	Stroke (Strokes) 01/2018
1	Cognitive Dysfunction 01/2018

Drug/Important Bio-Agent (IBA)

3	isosorbide-5-mononitrate (Ismo)FDA LinkGeneric 01/2022 - 01/2018
3	Cilostazol (Pletal)FDA LinkGeneric 01/2022 - 01/2018

Therapy/Procedure

1	Therapeutics 03/2021
1	Secondary Prevention 05/2019